STERIS To Invest $600 Million To Build Center Of Excellence In North Carolina

• This Formulated Chemistries Center of Excellence will support sterilization and disinfection for the global Healthcare and Pharmaceutical industries
• This strategic manufacturing investment is the largest in STERIS’s history in a single site
• New 600,000 square foot campus will create 335 jobs in North Carolina

Dublin, Ireland -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced that it will be investing $600 million to build a formulated chemistries manufacturing and distribution Center of Excellence in North Carolina, near the Raleigh-Durham Research Triangle region. The facility will serve as a central hub to produce high-performance infection prevention and contamination control chemistries used across the Healthcare and Pharmaceutical industries.

The construction of these facilities will include several phases, and the new site is expected to become operational in 2-3 years, starting with distribution. Upon completion, STERIS expects to transition its existing manufacturing and distribution of chemistries from St. Louis, Missouri and Plymouth, Minnesota to this new Center of Excellence.

“After extensive analysis of our existing facilities and Customer demand, we have decided to make a significant investment in the United States to support our long-term global growth,” said Dan Carestio, President and CEO of STERIS. “Creating a formulated chemistries Center of Excellence will allow us to accelerate innovation, expand capacity and optimize our U.S. chemistries manufacturing and distribution network. Our Customers save lives every day, and with this investment we will be well positioned to support their needs for years to come.”

This strategic manufacturing investment is the largest in STERIS history and was made after completing an evaluation of potential locations, including existing facilities. This state-of-the-art, 600,000 square-foot campus will create approximately 335 jobs in North Carolina for manufacturing, R&D, distribution and operations. North Carolina was selected due to, among other things, the availability of key technical knowledge and skills in a growing region. In addition, this investment is supported by the State of North Carolina, Lee County, the city of Sanford, and their associated economic development programs.

“STERIS is making a major investment in North Carolina, which reinforces our state’s reputation as a powerhouse in the life sciences industry,” said North Carolina Governor Josh Stein. “Decades of excellence in manufacturing and innovation have developed the world-class talent, research, and supply chain that continues to attract global companies and drive long-term economic growth across our state."

About STERIS

STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science products and services around the globe. For more information, visit www.steris.com.